Laurion Capital Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

Laurion Capital Management’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-12,381	Closed	-$45K	–	641
2022 Q2	$45K	Sell	12,381 -37,719	-75%	-$178K	﹤0.01%	432
2022 Q1	$303K	Buy	+50,100	New	+$305K	﹤0.01%	432

Other funds holding APEN

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Laurion Capital Management's APEN Position: Q3 2022 in Review

Laurion Capital Management sold out of Apollo Endosurgery, Inc. (APEN) in Q3 2022, closing a stake of 12,381 shares — an estimated $45K sold.

Laurion Capital Management first reported a position in APEN in Q1 2022 and held it in 2 quarters. The position peaked at $303K in Q1 2022. 53 funds tracked by Wall St. Rank hold APEN as of Q3 2022.

Laurion Capital Management reported no remaining Apollo Endosurgery, Inc. position as of Q3 2022 after selling out during the quarter.
Laurion Capital Management sold 12,381 Apollo Endosurgery, Inc. shares in Q3 2022, an estimated $45K.
Laurion Capital Management first reported a position in Apollo Endosurgery, Inc. in Q1 2022 and held it in 2 quarters.
Laurion Capital Management's Apollo Endosurgery, Inc. position peaked at $303K in Q1 2022.
53 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q3 2022.

Based on Laurion Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.